Since TLR4 promotes CTCs migration in pancreatic cancer and blocking TLR4 signaling inhibits CTCs migration and invasion, TLR4 appears to be a potential therapeutic target [135]. Here, TLR4 is linked to familial pancreatic carcinoma.